Art

J-GLOBAL ID：200902259075997723   Reference number：09A1279938

Association of TP53 and MDM2 polymorphisms with survival in bladder cancer patients treated with chemoradiotherapy

化学放射線療法で治療された膀胱癌患者におけるTP53およびMDM2多形と生存の関連

Author (9)： SHINOHARA Asano (Yamaguchi Univ., Yamaguchi, JPN) ,  SAKANO Shigeru (Yamaguchi Univ., Yamaguchi, JPN) ,  HINODA Yuji (Yamaguchi Univ., Yamaguchi, JPN) ,  NISHIJIMA Jun (Yamaguchi Univ., Yamaguchi, JPN) ,  KAWAI Yoshihisa (Yamaguchi Univ., Yamaguchi, JPN) ,  MISUMI Taku (Yamaguchi Univ., Yamaguchi, JPN) ,  NAGAO Kazuhiro (Yamaguchi Univ., Yamaguchi, JPN) ,  HARA Takahiko (Yamaguchi Univ., Yamaguchi, JPN) ,  MATSUYAMA Hideyasu (Yamaguchi Univ., Yamaguchi, JPN)
Material： Cancer Science  (Cancer Sci)
Volume： 100  Issue： 12  Page： 2376-2382  Publication year： Dec. 2009 
JST Material Number： W1423A  ISSN： 1347-9032  Document type： Article
Article type： 原著論文  Country of issue： Australia (AUS)  Language： ENGLISH (EN)

Thesaurus term： *bladder tumor ,...
Semi thesaurus term： cisplatin ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=09A1279938&from=J-GLOBAL&jstjournalNo=W1423A") }}

JST classification (2)： Urogenital tumors(=neoplasms)  (GM04000S) ,  Molecular genetics in general  (EC02010J)

Reference (42)：

• RODEL, C. Combined-modality treatment and selective organ preservation in invasive bladder cancer : long-term results. J Clin Oncol. 2002, 20, 3061-3071
• SHIPLEY, WU. Overview of bladder cancer trials in the Radiation Therapy Oncology Group. Cancer. 2003, 97, 2115-2119
• SHIPLEY, WU. Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy : initial results of Radiation Therapy Oncology Group 89-03. J Clin Oncol. 1998, 16, 3576-3583
• TESTER, W. Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer : results of Radiation Therapy Oncology Group phase II trial 8802. J Clin Oncol. 1996, 14, 119-126
• KACHNIC, LA. Bladder preservation by combined modality therapy for invasive bladder cancer. J Clin Oncol. 1997, 15, 1022-1029

Terms in the title (8)： 化学放射線療法 ,  治療 ,  膀胱 ,  癌患者 ,  TP53 ,  MDM2 ,  多形 ,  生存